Broadsheet number 55: Diagnosis of measles virus infection in the microbiology laboratory

Pathology

Volumn 32, Issue 2, 2000, Pages 102-106

  Smith, David W ^a  

^a Div of Microbiol and Infect Dis   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ACUTE DISEASE; ANTIGEN DETECTION; ARTICLE; CEREBROSPINAL FLUID; CLINICAL FEATURE; COMPLEMENT FIXATION TEST; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; LABORATORY DIAGNOSIS; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; POLYMERASE CHAIN REACTION; SALIVA; SEROLOGY; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS CULTURE; VIRUS DETECTION; VIRUS NEUTRALIZATION;

EID: 0034102435     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130200104321     Document Type: Article

References (40)

1. 1. Curran, M. Australia's notifiable disease status, 1996. Comm Dis Intell 1997; 21: 281-307.
2. 2. MMWR. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization and CDC. Morbid Mortal Weekly Rep 1997: 46(RR-11); 1-20.
3. 3. Forrest JM, Burgess MA, Heath TC, McIntyre PB. Measles control in Australia. Comm Dis Inlell 1998; 22: 33-6.
4. 4. Ferson MJ, Young LC, Robertson PW, Whybin LR. The difficulties in clinical diagnosis of measles: proposal for a modified clinical case definition. Med J Aust 1995; 163: 364-6.
5. 5. Bellini WJ, Rota PA. Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis 1998; 4: 29-35.
6. 6. Centers for Disease Control and Prevention: Current Trends Measles -United Sates, 1990. Morbid Mortal Weekly Rep 1991: 40; 369-72.
7. 7. Davidkin I, Valle M, Peltola H, et al. Etiology of measles-and rubella-like illnesses in measles, mumps and rubella-vaccinated children. J Infect Dis 1998; 178: 1567-70.
8. 8. Carter MJ, ter Meulen V. Measles. In: Zuckerman AJ, Banatvala JE, Pattison JR, editors. Principles and Practice of Clinical Virology, 2nd edn. Brisbane: Wiley 1990; 313-35.
9. 9. Oxman MN. Measles. In: Richman DD, Whitley RJ, Hayden FG, editors. Clinical Virology. Melbourne: Churchill Livingstone, 1997; 821-62.
10. 10. Minnich LL, Goodenough F, Ray CG. Use of immunofluorescence to identify measles virus infections. J Clin Microbiol 1991; 29: 1148-50.
11. 11. Smaron MF, Saxon E, Wood L, et al. Diagnosis of measles by fluorescent antibody and culture of nasopharyngeal secretions. J Virol Methods 1991; 33: 223-9.
12. 12. Kobune F, Sakata H, Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol 64: 700-5.
13. 13. Jin L, Richards A, Brown DW. Development of a dual target-PCR for detection and characterisation of measles virus in clinical specimens. Mol Cell Probes 1996; 10: 191-200.
14. 14. Matsuzono Y, Narita M, Ishiguro N, Togashi T. Detection of measles virus from clinical samples using the polymerase chain reaction. Arch Pediatr Adolesc Med 1994; 148: 289-93.
15. 15. Nakayama T, Mori T, Yamaguchi S, et al. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Res 1995; 35: 1-16.
16. 16. Godec MS, Asher DM, Swoveland PT, et al. Detection of measles virus genomic sequences in SSPE brain tissue by the polymerase chain reaction. J Med Virol 1990; 30: 237-44.
17. 17. Rota PA, Khan AS, Durigon E, et al. Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol 1995; 33: 2485-8.
18. 18. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titres. J Infect Dis 1990; 162: 1036-42.
19. 19. Neumann PW, Weber JM, Jessamine AG, O'Shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immuno-sorbent assay, and hemagglutination inhibition lest with neutralization test for determination of immune status. J Clin Microbiol 1985; 22: 296-8.
20. 20. Tuokko H. Detection of acute measles infections by indirect and μ-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. J Med Virol 1995; 45: 306-11.
21. 21. Helfland RF, Heath JL, Anderson LJ, et al. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen after rash onset. J Infect Dis 1997; 175: 195-9.
22. 22. Ozanne G, d'Halewyn M-A. Performance and reliability of the Enzygnost measles enzyme-linked immuno-sorbent assay for detection of measles virus-specific immunoglobulin M antibody during a large measles epidemic. J Clin Microbiol 1992; 30: 564-9.
23. 23. Rossier E, Miller H, McCulloch B, et al. Comparison of immunofluorescence and enzyme immunoassay for detection of measles-specific immunoglobulin M antibody. J Clin Microbiol 1991; 29: 1069-71.
24. 24. Nates S, Rey G, Giordano M, et al. Immunoglobulin M antibody responses to measles virus following natural infection, primary vaccination and reexposure to the virus. Viral Immunol 1997; 10: 165-73.
25. 25. George JR, Fitchen JH. Future applications of oral fluid specimen technology. Am J Med 1997; 102: 21-5.
26. 26. Thieme T, Piacentini S, Davidson S, Steingart K. Determination of measles, mumps and rubella immunization status using oral fluid samples. J Am Med Assoc 1994; 272: 219-21.
27. 27. Calvert N, Cutts F, Irving R, et al. Measles immunity and response to revaccination among secondary school children in Cumbria. Epidemiol Infect 1996; 116: 65-70.
28. 28. Brown DW, Ramsay ME, Richards AF, Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom 1991-3. Br Med J 1994; 308: 1015-7.
29. 29. Helfand RF, Kebede S, Alexander JP Jr, et al. Comparative detection of measles-specific IgM in oral fluid and serum from children by an antibody-capture IgM EIA. J Infect Dis 1996; 173: 1470-4.
30. 30. Helfland RF, Gary HE Jr, Alkinson WL, et al. Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination. Clin Diagn Lab Immunol 1998; 5: 135-8.
31. 31. Erdman DD, Heath JL, Watson JC, et al. Immunoglobulin M antibody response to measles virus infection following primary and secondary vaccination and natural virus infection. J Med Virol 1993; 41: 44-8.
32. 32. Abdelnoor AM, Dhib-Jalbut SS, Haddad FS. Different virus antibodies in serum and cerebrospinal fluid of patients suffering from subacute sclerosing panencephalitis. J Neuroimmunol 1982; 2: 27-34.
33. 33. Connolly JH, Allen IV, Hurwitz LJ, Millar JHD. Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 1967; i: 542-4.
34. 34. Kapil A, Broor S, Seth P. Prevalence of SSPE: a serological study. Indian Pediatr 1992; 29: 731-4.
35. 35. Kiessling WR, Hall WW, Yung LL, ter Meulen V. Measles-virus-specific-immunoglobulin-M response in subacute sclerosing panencephalitis. Lancet 1977; i: 324-7.
36. 36. Melioli G, Pedulla D, Merli AL, et al. A simple method to detect intrathecal production of specific antimeasles antibodies in cerebrospinal fluid during subacute sclerosing panencephalitis. Diagn Microbiol Infect Dis 1985; 3: 411-7.
37. 37. Robbins SJ, Fiumara F, Appleton B, Burke C. Subacute sclerosing panencephalitis (SSPE): a report of 16 cases. Aust NZ J Med 1984; 14: 126-30.
38. 38. Dyken PR, Swift A, DuRant RH. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol 1982; 11: 359-64.
39. 39. Chiodi F, Sundqvist V-A, Norrby E, et al. Measles IgM antibodies in cerebrospinal fluid and serum in subacute sclerosing panencephalitis. J Med Virol 1986; 18: 149-58.
40. 40. Jabbour JT, Duenas DA, Sever JL, et al. Epidemiology of subacute sclerosing panencephalitis (SSPE). J Am Med Assoc 1972; 220: 959-62.